Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK462 10 mg p.o. in the Treatment of Multiple Attacks of Migraine Headache

NCT00899379 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00899379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00899379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK462 10 mg p.o. in the Treatment of Multiple Attacks of Migraine Headache
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1995
Completion date
April 30, 1996
Enrollment
473 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache